Unlabelled: Background/Objections: The pharmacological management of Parkinson's Disease (PD) is often supplemented by deep brain stimulation (DBS) to tackle problems of advanced disease such as motor fluctuation, dyskinesias or medication-resistant tremor. DBS uses high-frequency stimulation with spatially distributed electrodes to produce electrical fields that influence neuronal networks. The programming of such stimulation is complex and time-consuming. Recent technological advancements have enabled DBS systems to record local field potentials (LFPs). In conjunction with biomarker discovery, such as beta oscillations, this shows promise in streamlining the DBS programming process. This review aims to synthesize the current literature investigating LFP characteristics in PD in order to understand the place of LFPs in assisting with DBS programming.
Methods: A comprehensive literature search was conducted using databases including OVID MEDLINE, Scopus, and Cochrane Library, resulting in 738 identified articles; 122 studies remained after screening and 87 studies were selected for detailed analysis.
Results: Analyzing LFPs clearly has the potential to assist or streamline DBS programming in clinical practice, but there are knowledge gaps and challenges to overcome, especially in the utilization of intraoperative LFPs.
Conclusions: More research is required to compare different algorithms that utilize LFPs in DBS programming to identify a simple, practical and time-saving algorithm incorporating reliable LFP biomarkers that will enhance the DBS programming experience for both patients and clinicians.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11853521 | PMC |
| http://dx.doi.org/10.3390/brainsci15020116 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Modulating inhibitory synaptic plasticity to restore basal ganglia dynamics in Parkinson's disease.
Brain
March 2025
Krembil Brain Institute, University Health Network, Toronto, ON M5T 1M8, Canada.
Parkinson's disease is characterized, in part, by hypoactivity of direct pathway inhibitory projections from striatum to the globus pallidus internus (GPi) and indirect pathway inhibitory projections from globus pallidus externus (GPe) to the subthalamic nucleus (STN). In people with Parkinson's disease (n=32), we explored the potential use of intracranial stimulation for eliciting long-term potentiation (LTP) of these underactive pathways to produce improvement of symptoms that persists beyond stimulation cessation. During GPi deep brain stimulation (DBS) surgery, we found strong evidence (p<.
View Article and Find Full Text PDFProceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications.
Front Hum Neurosci
February 2025
Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses of existing technology as well as next-generation technology. Our keynote speaker shared the vision of using neuro artificial intelligence to predict depression using brain electrophysiology.
View Article and Find Full Text PDFRhythmic Eyelid Closure Responsive to STN-DBS: Blepharoclonus, Blepharospasm, Eyelid Opening Apraxia, or Eyelid Tremor?
Mov Disord Clin Pract
March 2025
Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, University Health Network, and Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
Optimizing Biotinidase Activity Assays: Insights From Clinical and Laboratory Evaluation From a Low-Middle Income Country.
Cureus
February 2025
Pathology and Laboratory Medicine, Aga Khan University, Karachi, PAK.
Objective This study aimed to verify the methods used for biotinidase deficiency (BTD) assays, including fluorometric and colorimetric techniques, measure biotinidase (BT) activity in dried blood spots (DBS) and serum samples, and explore the clinical spectrum of patients with BTD based on low serum BT activity. Methods A cross-sectional study was conducted at the Newborn Screening Lab, Aga Khan University, Karachi, following ethical approval from August 2021 to December 2024. The study was conducted in three phases.
View Article and Find Full Text PDFSex differences in long-term fear and anxiety-like responses to deep brain stimulation in a preclinical model of PTSD.
J Psychiatr Res
February 2025
. Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada; . Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada; . Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, M4N 3M5, Canada. Electronic address:
Deep brain stimulation (DBS) is currently being investigated in patients and preclinical models of posttraumatic stress disorder (PTSD), but differences in behaviour according to sex remain elusive. We exposed female and male rats to fear conditioning and extinction. Thereafter, animals were treated with ventromedial prefrontal cortex DBS, followed by a battery of tests to measure fear and anxiety-like behaviour.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!